Gallbladder cancer overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
<div style="-webkit-user-select: none;">
<div style="-webkit-user-select: none;">
{|class="infobox" style="position: fixed; top: 65%; right: 10px; margin: 0 0 0 0; border: 0; float: right;
{| class="infobox" style="position: fixed; top: 65%; right: 10px; margin: 0 0 0 0; border: 0; float: right;"
|-
|-
| {{#ev:youtube|https://https://www.youtube.com/watch?v=WsmW6I0cmBE|350}}
| {{#ev:youtube|https://https://www.youtube.com/watch?v=WsmW6I0cmBE|350}}
Line 10: Line 10:


==Overview==
==Overview==
Gallbladder is a small, pear-shaped organ at the right side of the abdomen, just below the liver. The gallbladder stores bile, a digestive fluid produced through your liver.Gallbladder cancer is hard to diagnose because it often causes no specific signs and symptoms and also the hidden nature of the gallbladder makes it complicated for gallbladder cancer to develop with out being detected.Gallbladder cancer (GBC) is an uncommon however highly fatal malignancy.Gallbladder cancer is the most common malignant tumour of the biliary tract .the majority are found incidentally in patients undergoing exploration for cholelithiasis. due both to the anatomic position of the gallbladder, and the vagueness and nonspecificity of signs and symptoms GBC is concept to be related to advanced stage at diagnosis.The only chance for a complete cure is by surgical resection
===Classification===
===Classification===
Gallbladder cancer may be classified according to histology findings into various subtypes.
Gallbladder cancer may be classified according to histology findings into various subtypes and are as follows
 
Adenocarcinoma, Papillary adenocarcinoma, Mucinous adenocarcinoma, Signet ring cell carcinoma, Adenosquamous carcinoma, Squamous cell carcinoma, Neuroendocrine carcinoma, Small cell carcinoma, Undifferentiated carcinoma, Spindle cell undifferentiated carcinoma, Gaint cell undifferentiated carcinoma


===Pathophysiology===
===Pathophysiology===
The pathophysiology of gallbladder cancer depends on the histologic subtypes.
It is understood that GBC is the result of persistent irritation of the gallbladder mucosa over a period of years which predispose to malignant transformation or act as an enhancer for carcinogenic exposure.The primary mechanism involves cholelithiasis and resultant cholecystitis and appears to be the driving force in most areas of the arena.Chronically inflamed gallbladder may additionally express both pyloric gland and intestinal metaplasia.But, fluke-infested gallbladders more commonly shows intestinal metaplasia and p53 mutations than sporadic gallbladder cancers.Dysplastic lesions have molecular genetic proof that supports progression towards CIS.There are also histologic and molecular differences in GBCs related to anomalous pancreaticobiliary duct junction and in the ones related to gallstones, Providing further proof that two different pathogenetic pathways are involved.Less than 3% of early gallbladder carcinomas have adenomatous remnants, indicating this mechanism has less importance within the carcinogenic pathway.


===Epidemiology and Demographics===
===Epidemiology and Demographics===
In 2015, the number of new cases of gallbladder cancer was estimated to be 10,910 in United States. Females are more commonly affected with gallbladder cancer than males, the female to male ratio is approximately 5 to 1.
Around 80 t0 95% of biliary tract cancers are gallbladder cancers.[[Epidemiology|Epidemiological]] research has recognized striking geographic and ethnic difference. An excessive incidence in American Indians and Southeast Asia, but pretty low in the America and the arena.


===Risk factors===
===Risk factors===
Common risk factors in the development of gallbladder cancer are obesity, chronic cholecystitis, chronic cholelithiasis, chronic typhoid infection, alcohol and genetic mutations.
Gallstones, Porcelain gallbladder, Gallbladder polyps, Primary sclerosing cholangitis (PSC) , Chronic infection, Congenital biliary cysts, Pancreaticobiliary maljunction (PBM)


===Screening===
===Screening===
There is no screening recommended for gallbladder cancer.
There is no screening recommended for gallbladder cancer. According to the National Comprehensive Cancer Network (NCCN) guidelines, gallbladder cancer may be diagnosed as an accidental finding in patients who undergo [[laparoscopic]] [[cholecystectomy]].


===Differential Diagnosis===
===Differential Diagnosis===
Line 29: Line 33:


===Natural history, Complications and prognosis===
===Natural history, Complications and prognosis===
Depending on the extent of the tumor at the time of diagnosis, the prognosis is generally regarded as poor.
Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor.Most tumors are [[Adenocarcinoma|adenocarcinomas]], with a small percent being [[squamous cell]] carcinomas. The cancer commonly spreads to the [[liver]], [[pancreas]], [[stomach]] and [[duodenum]]. The survival rate depends on the extent of cancer at the time of diagnosis with gallbladder cancer and Early detection is key for good prognosis


===Staging===
===Staging===

Revision as of 20:41, 30 January 2018

https://https://www.youtube.com/watch?v=WsmW6I0cmBE%7C350}}

Gallbladder cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Gallbladder cancer from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Palliative Treatment

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gallbladder cancer overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gallbladder cancer overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gallbladder cancer overview

CDC on Gallbladder cancer overview

Gallbladder cancer overview in the news

Blogs on Gallbladder cancer overview

Directions to Hospitals Treating Gallbladder cancer

Risk calculators and risk factors for Gallbladder cancer overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Overview

Gallbladder is a small, pear-shaped organ at the right side of the abdomen, just below the liver. The gallbladder stores bile, a digestive fluid produced through your liver.Gallbladder cancer is hard to diagnose because it often causes no specific signs and symptoms and also the hidden nature of the gallbladder makes it complicated for gallbladder cancer to develop with out being detected.Gallbladder cancer (GBC) is an uncommon however highly fatal malignancy.Gallbladder cancer is the most common malignant tumour of the biliary tract .the majority are found incidentally in patients undergoing exploration for cholelithiasis. due both to the anatomic position of the gallbladder, and the vagueness and nonspecificity of signs and symptoms GBC is concept to be related to advanced stage at diagnosis.The only chance for a complete cure is by surgical resection

Classification

Gallbladder cancer may be classified according to histology findings into various subtypes and are as follows

Adenocarcinoma, Papillary adenocarcinoma, Mucinous adenocarcinoma, Signet ring cell carcinoma, Adenosquamous carcinoma, Squamous cell carcinoma, Neuroendocrine carcinoma, Small cell carcinoma, Undifferentiated carcinoma, Spindle cell undifferentiated carcinoma, Gaint cell undifferentiated carcinoma

Pathophysiology

It is understood that GBC is the result of persistent irritation of the gallbladder mucosa over a period of years which predispose to malignant transformation or act as an enhancer for carcinogenic exposure.The primary mechanism involves cholelithiasis and resultant cholecystitis and appears to be the driving force in most areas of the arena.Chronically inflamed gallbladder may additionally express both pyloric gland and intestinal metaplasia.But, fluke-infested gallbladders more commonly shows intestinal metaplasia and p53 mutations than sporadic gallbladder cancers.Dysplastic lesions have molecular genetic proof that supports progression towards CIS.There are also histologic and molecular differences in GBCs related to anomalous pancreaticobiliary duct junction and in the ones related to gallstones, Providing further proof that two different pathogenetic pathways are involved.Less than 3% of early gallbladder carcinomas have adenomatous remnants, indicating this mechanism has less importance within the carcinogenic pathway.

Epidemiology and Demographics

Around 80 t0 95% of biliary tract cancers are gallbladder cancers.Epidemiological research has recognized striking geographic and ethnic difference. An excessive incidence in American Indians and Southeast Asia, but pretty low in the America and the arena.

Risk factors

Gallstones, Porcelain gallbladder, Gallbladder polyps, Primary sclerosing cholangitis (PSC) , Chronic infection, Congenital biliary cysts, Pancreaticobiliary maljunction (PBM)

Screening

There is no screening recommended for gallbladder cancer. According to the National Comprehensive Cancer Network (NCCN) guidelines, gallbladder cancer may be diagnosed as an accidental finding in patients who undergo laparoscopic cholecystectomy.

Differential Diagnosis

Gallbladder cancer must be differentiated from hepatitis, gallstones, cholecystitis, peptic ulcer, pancreatic cancer and pancreatitis.

Natural history, Complications and prognosis

Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor.Most tumors are adenocarcinomas, with a small percent being squamous cell carcinomas. The cancer commonly spreads to the liverpancreasstomach and duodenum. The survival rate depends on the extent of cancer at the time of diagnosis with gallbladder cancer and Early detection is key for good prognosis

Staging

According to the AJCC, there are 4 stages of gallbladder cancer based on the tumor spread.

History and symptoms

Symptoms of gallbladder cancer include jaundice, pain, fever, burping and weight loss.

Laboratory findings

Laboratory findings consistent with the diagnosis of gallbladder cancer include abnormal liver function tests and elevated CA 19-9 and CEA levels.

CT

On abdominal CT scan, gallbladder cancer appears as large heterogeneous mass with areas of necrosis.

MRI

MRI combined with magnetic resonance cholangiography may be helpful in the diagnosis of gallbladder cancer metastasis.

Other imaging findings

PET scan may be helpful in the diagnosis of gallbladder cancer.

Medical therapy

The therapy for gallbladder cancer depends largely on the disease progression and the stage of cancer.

Surgery

The mainstay of therapy for gallbladder cancer is surgery.

Palliative treatment

Palliative therapy in gallbladder cancer involves percutaneous transhepatic radiologic catheter bypass or endoscopically placed stents, standard external-beam radiation therapy, palliative surgery or standard chemotherapy.

Primary Prevention

Research suggests that lifestyle factors such as changes in diet, exercise, and maintenance of weight can influence the likelihood of an individual developing gallbladder cancer.

References


Template:WikiDoc Sources